Cardiovascular Disease Prediction by Machine Learning Algorithms Based on Cytokines in Kazakhs of China

Yunxing Jiang1, Xianghui Zhang1, Rulin Ma1

  • 1Department of Public Health, Shihezi University School of Medicine, Shihezi, Xinjiang, People's Republic of China.

Clinical Epidemiology
|June 17, 2021
PubMed

Insights

Machine learning models, including logistic regression (LR) and support vector machine (SVM), show promise in predicting cardiovascular disease (CVD) risk in Kazakh Chinese populations. Inflammatory markers like hs-CRP and IL-6 are key predictors.

Area of Science:

  • Cardiovascular Health
  • Machine Learning Applications
  • Biomarker Discovery

Background:

  • Cardiovascular disease (CVD) is a leading global cause of mortality.
  • Accurate CVD risk identification is crucial for improving patient outcomes.
  • This study evaluates seven machine learning (ML) algorithms for CVD risk prediction.

Purpose of the Study:

  • To systematically assess the feasibility and performance of ML algorithms in predicting CVD risk.
  • To identify the most effective ML models for CVD risk stratification.
  • To explore the predictive power of various clinical and biological variables.

Main Methods:

  • 1508 Kazakh subjects without baseline CVD were analyzed.
  • Data was split into training (80%) and testing (20%) sets.
  • Seven ML algorithms (LR, SVM, DT, RF, KNN, NB, XGB) were employed, with 10-fold cross-validation for tuning.

Main Results:

  • 203 CVD cases were diagnosed during a median follow-up of 5.17 years.
  • All models demonstrated moderate to excellent discrimination (AUC 0.770-0.872) and good calibration.
  • Logistic Regression (LR) and Support Vector Machine (SVM) showed high performance, with LR achieving the highest sensitivity (97.1%).
  • Inflammatory cytokines, including hs-CRP and IL-6, were identified as significant CVD predictors.

Conclusions:

  • LR and SVM models are suitable for clinical decision-making in the Kazakh Chinese population for CVD risk assessment.
  • Further research is needed to validate and refine these models' accuracy.
  • Inflammatory markers are important predictors for CVD risk in this population.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
464
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
563
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
283